Medical device design and manufacturing company Kelyniam Global Inc has acquired MED-ALLY, LLC as part of its product diversification initiative.
A protein that stimulates the brain to awaken from sleep may be a target for preventing Alzheimer’s disease, a study by researchers at Washington University School of Medicine in St Louis suggests.
Teens prescribed antianxiety or sleep medications may be up to 12 times more likely to abuse those drugs illegally than teens who have never received a prescription.
Aiming to discern discrete neural circuits, researchers at the University of Wisconsin-Madison have tracked electrical activity in the brains of people who alternately imagined scenes or watched videos.
Massachusetts General Hospital (MGH) investigators have developed a system to accurately track the dynamic process of falling asleep, something that has not been possible with existing techniques.
Not all circadian cycles peak at the same time-some peak in the morning and others in the evening. The question, is, how does a single clock keep time in multiple phases at once?
A drug-free treatment will be trialed for people with symptoms of insomnia and obstructive sleep apnea in Brisbane, Australia.
In a special investigation report issued yesterday, the National Transportation Safety Board (NTSB) made several recommendations to Metro-North regarding the need for better sleep disorder screening of its employees.
Brain training program Lumosity presented research yesterday at the 2014 Society for Neuroscience conference on how lifestyle factors such as sleep, mood, and time of day impact cognitive gameplay performance.
SWAN Sleep Solutions, which partners with companies to roll out employee sleep initiatives, recently collected data from five US corporations in diverse sectors. In its white paper “Sleep in American Business,” it reports that there are significant areas for improvement in both sleep quality and sleep duration among American employees.